Investment Thesis
Aglaia is an oncology-focused investor that selects and matures early-stage companies developing cancer prevention, diagnosis, and treatment innovations.
Stage Focus
Early-stage
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Early-stage breakthrough inventions in oncology with transformative potential
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
N/A
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
